那屈肝素钙治疗急性脑梗死

目的 :探索那屈肝素钙治疗脑梗死的疗效及治疗前后凝血因子I(Fg) ,凝血因子Ⅱ (昔名凝血酶原 )时间 (PT) ,血小板粘附率 (PAR) ,总胆固醇(TC)及三酰甘油 (TG)的变化。方法 :4 0例脑梗死病人 男性 2 8例 ,女性 12例 ,年龄 (6 4±s9)a],除常规治疗 (甘露醇、尼莫地平等 )外 ,给予那屈肝素钙0 .4mL(4 10 0IUAXa)sc ,bid× 10d ,治疗前后测定Fg ,PT ,PAR ,TC及TG并以 38例脑梗死病人用常规治疗为对照组。结果 :治疗组显效率 72 % ,2组疗效差异有显著意义 (P <0 .0 5)。治疗前后Fg降低(0 .7± 2 .0 ) g·L- 1,PT延长 (3± 9)s ,PAR降低(3.9± 2 .0 ) % ,差异有非常显著意义 (P <0 .0 1或P<0 .0 5) ,血脂改变无显著意义 (P >0 .0 5)。结论 :那屈肝素钙具有抗凝溶栓作用 ,对急性脑梗死有效 ,且无增加再出血的危险。

Nadroparin calcium in treatment of acute cerebral infarction

AIM: To understand the therapeutic effects of nadroparin calcium and the variations of fibrinogen(Fg),prothrombin time(PT),platelet adhesion rate(PAR),TC and TG before and after treatment. METHODS: Patients( n =40) with acute cerebral infarction M 28, F 12, age (64± s 9) a] recieved 0.4 mL of nadroparin calcium(4100 IUAXa),bid,sc for 10 d besides conventional therapy (mannitol, nimodipine, etc). The Fg,PT,PAR, TC and TG of the patients before and after the treatment were determined and compared with those of the control group of 38 patients of the same disease. RESULTS: One course of treatment with nadroparin calcium showed a statistically significant effective rate of 72 % ( P <0.05). The Fg was lowered (0.7± 2.0) g·L -1 ; the PT was lengthened(3±9)s;the PAR was reduced (3.9±2.0)% very significanly( P < 0.01 );the blood lipids did not changed( P >0.05) significantly. CONCLUSION: Nadroparin calcium is effective in combating coagulation and treating acute cerebral infarction with no hazard of reoccurrence of hemorrhage.